Skip to main content
. 2013 Jul 18;13:328. doi: 10.1186/1471-2334-13-328

Table 3.

Pre-S region mutations and deletions

 
Clinical group
Genotype
Pre-S2 S tart codon
Deletions
 
 
 
 
Region
Nucleotides
Amino acids
Region and functions affected
ID         Size Position Size position  
SDAC024
CR
D
ATG
Pre-S2
21
35-55a
7
16-22a
 
SDAC048
CR
D
ATG
Pre-S1
72
2998-3069
24
51-74
S promoter, Transactivator domain
SDAC083
CR
D
ATG
Pre-S2
21
35-55
7
16-22
 
SDAC097
CR
D
GTGb
Pre-S 2
9
45- 53
3
19-21
 
SDAC098
CH
D
ATG
Pre-S1
18
3129-3146
6
94-99
Hsc70 binding site, CCAAT binding factor (CBF) binding site, Cytosolic anchorage determinant (CAD)
SDAC112
ASC
D
ATG
Pre-S2
6
49-54
2
20-21
 
SDAC118
CR
D
ATG
Pre-S2
54
4-57
18
5 to 22
pHSA binding site, Viral secretion
SDAC107
CR
D
ATA
-
-
-
-
-
-
SDAC090
CR
D
ATA
-
-
-
-
-
-
SDAC058
CR
E
ATG
Pre-S2
9
58-66c
3
20-22c
Transactivator domain
SDAC059
HCC
E
GTG
Pre-S2
12
52-63
4
18-21
Transactivator domain
SDAC088
HCC
E
ATG
Pre-S2
12
52-63
4
18-21
Transactivator domain
SDAC095
HCC
E
ATG
Pre-S2
15
52-66
5
18-22
Transactivator domain
SDAC067
ASC
E
GTG
-
-
-
-
-
-
SDAC113 ASC A ACA - - - - - -

a nucleotide or amino acid position relative to genotype D (GU456684).

b mutant pre-S2 start codon italicized.

c nucleotide or amino acid position relative to genotype E (AB205191).